Navigation Links
Irving Dark Named Vice President of Cytel Clinical Research Services
Date:1/16/2008

Proven Executive Brings Both Clinical Trial Experience and Business

Development Leadership to Clinical Trial Services Management Role

CAMBRIDGE, Mass., Jan. 16 /PRNewswire/ -- Cytel, Inc. announced today that clinical research and business development executive Irving Dark has accepted the role of Vice President of Cytel Clinical Research Services. Mr. Dark brings to Cytel 15-years of management experience guiding drug, biologic and medical device products successfully through the development process as well as growing commercial clinical research organizations.

In his new position, Mr. Dark will head and drive the growth of Cytel's cutting-edge clinical trial design and implementation services to the biopharmaceutical industry.

Prior to joining Cytel, Mr. Dark was Vice President, Business Development and Operations for Veristat, Inc. During his tenure he established and oversaw the company's Data Management, Project Management, and Business Development departments. Mr. Dark was integrally involved with Veristat's Corporate Compliance activities to ensure adherence with regulatory and GCP guidelines, and was instrumental in the company's oncology and influenza contracts, and the Acambis smallpox vaccine program.

Previously, Mr. Dark held several key positions at full-service trial leader PAREXEL, rising from statistical programming management to overseeing the planning and conduct of phase 1, 2, and 3 global clinical trials.

"Irving's experience in trial management and his knowledge of the clinical development needs of the biopharmaceutical industry are ideally suited to growing Cytel's innovative clinical research services" said Ranganath Nayak, Chief Executive Officer of Cytel.

"Cytel has an impressive track record delivering innovative solutions to the biopharmaceutical industry," said Irving Dark. "Cytel's experience designing innovative clinical trials and its advanced analytical capabilities differentiate our trial services from those offered by traditional CRO's. I am delighted to be joining the management team at such an exciting time for the company."

About Cytel

Celebrating its 20th anniversary, Cytel Inc. is a leading provider of clinical trial consulting services, specialized statistical software, and outsourced clinical study reports for the biopharmaceutical, medical device, academic, and research institute markets. Cytel's validated trial designs and implementation services reduce development time and costs while increasing the probability of clinical success. Cytel Inc. is headquartered in Cambridge, MA, with facilities in Philadelphia, PA and Pune, India.


'/>"/>
SOURCE Cytel Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Panacea Pharmaceuticals Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazines Ten Biggest Medical Breakthroughs of 2007
2. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
3. Kent Riddle Named To Piedmont Triad Biotechnology Development Group
4. Deloitte Chairman of the Board Sharon L. Allen Named Chairman of the American Friends of the Phelophepa Train
5. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
6. K-States Subbaratnam Muthukrishnan and Barbara Valent Named Fellows of the American Association for the Advancement of Science
7. Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry
8. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
9. Cynthia Haines, M.D., Named Managing Editor of Physicians Briefing News Wire
10. DuPont Named Among Top Biotechnology Employers by Science Magazine
11. Abaxis CEO Clint Severson Named Entrepreneur of the Year by Forbes Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... Opal Kelly, a leading ... PCI Express, announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB ... sized form factor suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB ...
(Date:1/18/2017)...   Boston Biomedical , an industry leader in ... stemness pathways, will feature data from two clinical studies ... ASCO Gastrointestinal Cancers Symposium, held from January 19-21, in ... Napabucasin is an orally-administered investigational agent designed to inhibit ... stem cells (CSCs) possess the property of stemness – ...
(Date:1/18/2017)... , Jan. 18, 2017   Parent Project ... fight to end Duchenne muscular dystrophy (Duchenne) , ... the New Jersey Institute of Technology (NJIT) and Talem ... exploration of robotic technology to assist people living ... incorporate NJIT,s technology – an embedded computer, software, a ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place on Wednesday, January ... NY. The procedure was an anterior cervical discectomy and fusion on a 42 ...
Breaking Biology Technology:
(Date:1/19/2017)... 19, 2017 According to a new report published by ... - 2022," the global biometric sensor market is expected to garner $1.5 billion ... 2015, Asia-Pacific dominated the global market and contributed over ... Continue Reading ... ...
(Date:1/18/2017)... ROCKVILLE, Md. , Jan. 18, 2017  In ... with respect to mergers and acquisitions (M&A), and Kalorama ... reasons for such acquisitions have been shifting. Generally, uncertainty ... and the U.S. has changed the acquisitions ... situation has resulted in companies buying partners outside of ...
(Date:1/13/2017)... WASHINGTON, N.Y. , Jan. 13, 2017 /PRNewswire/ ... of technology solutions for the homecare industry, including ... of homecare industry expert, Justin Jugs, as Senior ... brings more than 15 years of homecare experience ... team in developing strategic plans to align Sandata,s ...
Breaking Biology News(10 mins):